Search by Drug Name or NDC
NDC 68134-0603-30 Clonidine 0.17 mg/1 Details
Clonidine 0.17 mg/1
Clonidine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PALMETTO PHARMACEUTICALS INC.. The primary component is CLONIDINE.
MedlinePlus Drug Summary
Clonidine tablets (Catapres) are used alone or in combination with other medications to treat high blood pressure. Clonidine extended-release (long-acting) tablets (Kapvay) are used alone or in combination with other medications as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in children. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. Clonidine treats high blood pressure by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Clonidine extended-release tablets may treat ADHD by affecting the part of the brain that controls attention and impulsivity. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 68134-0603-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Clonidine
Product Information
| NDC | 68134-0603 |
|---|---|
| Product ID | 68134-603_0eb6eb87-c779-3b79-e063-6294a90a5944 |
| Associated GPIs | |
| GCN Sequence Number | 066917 |
| GCN Sequence Number Description | clonidine HCl TAB ER 24H 0.17 MG ORAL |
| HIC3 | A4B |
| HIC3 Description | ANTIHYPERTENSIVES, SYMPATHOLYTIC |
| GCN | 29347 |
| HICL Sequence Number | 000113 |
| HICL Sequence Number Description | CLONIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Clonidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clonidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 0.17 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLONIDINE |
| Labeler Name | PALMETTO PHARMACEUTICALS INC. |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA022500 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68134-0603-30 (68134060330)
| NDC Package Code | 68134-603-30 |
|---|---|
| Billing NDC | 68134060330 |
| Package | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68134-603-30) |
| Marketing Start Date | 2022-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |